Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

103 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Histone deacetylase inhibitors.
Marks PA, Richon VM, Miller T, Kelly WK. Marks PA, et al. Among authors: richon vm. Adv Cancer Res. 2004;91:137-68. doi: 10.1016/S0065-230X(04)91004-4. Adv Cancer Res. 2004. PMID: 15327890 Review.
Histone deacetylases.
Marks PA, Miller T, Richon VM. Marks PA, et al. Among authors: richon vm. Curr Opin Pharmacol. 2003 Aug;3(4):344-51. doi: 10.1016/s1471-4892(03)00084-5. Curr Opin Pharmacol. 2003. PMID: 12901942 Review.
Suberoylanilide hydroxamic acid (vorinostat) represses androgen receptor expression and acts synergistically with an androgen receptor antagonist to inhibit prostate cancer cell proliferation.
Marrocco DL, Tilley WD, Bianco-Miotto T, Evdokiou A, Scher HI, Rifkind RA, Marks PA, Richon VM, Butler LM. Marrocco DL, et al. Among authors: richon vm. Mol Cancer Ther. 2007 Jan;6(1):51-60. doi: 10.1158/1535-7163.MCT-06-0144. Epub 2007 Jan 11. Mol Cancer Ther. 2007. PMID: 17218635
103 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page